jordi.barquinero@vhir.org
BARQUINERO MAÑEZ, JORDI
iMarina ID: 04-855Grup
Teràpia cel.lular i gènica. Vall d'Hebron Institut de Recerca (VHIR). Passeig de la Vall d'Hebron. Barcelona. 08035
Grup
SICARDPATH. Vall d'Hebron Institut de Recerca (VHIR). Passeig de la Vall d'Hebron. Barcelona. 08035
Codis d'identificació
Cronologia
gener de 1992
Doctorat: Doctor en Medicina
Universitat Autònoma de Barcelona
juny de 1982
Titulat superior / Grau: Licenciado en Medicina y Cirugía
Universitat Autònoma de Barcelona
Cronologia
gener de 2016
Investigador/a
Vall d'Hebron Institut de Recerca (VHIR). SICARDPATH
2016 -
gener de 2016
Investigador/a
Vall d'Hebron Institut de Recerca (VHIR). Teràpia cel.lular i gènica
2016 -
gener de 2007
Investigador sènior
Vall d'Hebron Institut de Recerca (VHIR). Teràpia cel.lular i gènica
2007 -
octubre de 2001
Investigador Miguel Servet. FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL UNIV. VALL D'HEBRON
2001 - 2007
febrer de 2001
Sénior
Vall d'Hebron Institut de Recerca (VHIR). SICARDPATH
2001 -
febrer de 2001
Sénior
Vall d'Hebron Institut de Recerca (VHIR). Teràpia cel.lular i gènica
2001 -
gener de 1995
Investigador II. Institut de Recerca Oncològica
Institut de Recerca Oncológica
1995 - 2001
novembre de 1992
Investigador Postdoctoral. Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
1992 - 1994
gener de 1991
Médico adjunto de Urgencias. Hospital de La Esperanza
Hospital de La Esperanza
1991 - 1991
juliol de 1990
Experiencia Sanitaria. Hospital de la Esperanza, Barcelona, Spain
Hospital de la Esperanza, Barcelona, Spain
1990 - 1991
gener de 1990
Becario Predoctoral. University of Louisville
University of Louisville
1990 - 1990
abril de 1989
Médico Adjunto de Urgencias (UCI). Hospital Vall d'Hebron
HOSPITAL VALL D'HEBRON
1989 - 1989
gener de 1989
Experiencia Sanitaria. Centro Médico Sitges
Centro Médico Sitges
1989 - 1991
gener de 1989
Experiencia Sanitaria. Centro Médico Sitges
General Practitioner
1989 - 1991
abril de 1984
Residente de Medicina Interna. Hospital Vall d'Hebron
HOSPITAL VALL D'HEBRON
1984 - 1989
abril de 1984
Experiencia Sanitaria. Hospital Vall d'Hebron, Barcelona, Spain
Hospital Vall d'Hebrón, Barcelona, Spain
1984 - 1990
gener de 1983
Alférez médico. Hospital Militar de Mahón
Hospital Militar de Mahón
1983 - 1983
gener de 1983
Experiencia Sanitaria. Military Hospital Cuesta Monereo
Military Hospital "Cuesta Monereo"
1983 - 1983
Reconeixements Investigació
Reconeixements Docents
Temàtiques més freqüents
Temáticas
Projectes participats
Direcció y participació en projectes
IP
NO IP
Grups, xarxes
Activitat docent
Tesi Dirigides
7
Centres
Universitat Internacional de Catalunya
Assignatura/Curs
Publicacions en Altmetrics
| 2020 | Variable readthrough responsiveness of nonsense mutations in hemophilia A | |
| 2020 | Absence of p.R50X Pygm read-through in McArdle disease cellular models | |
| 2019 | Terapia génica de la hemofilia y otras enfermedades de la sangre | |
| 2019 | Successful engraftment of gene-corrected hematopoietic stem cells in non-conditi... | |
| 2018 | Expression of microRNA-155 in inflammatory cells modulates liver injury | |
| 2017 | Advanced cell-based modeling of the royal disease: characterization of the mutat... | |
| 2017 | A reproducible method for the isolation and expansion of ovine mesenchymal strom... | |
| 2017 | Response of the human myocardium to ischemic injury and preconditioning: The rol... | |
| 2017 | Myeloid-derived suppressor cells can be efficiently generated from human hematop... | |
| 2016 | Myeloid-derived suppressor cells expressing a self-antigen ameliorate experiment... | |
| 2016 | Long-term restoration of thymidine phosphorylase function and nucleoside homeost... | |
| 2015 | Prospective therapeutic approaches in mitochondrial neurogastrointestinal enceph... | |
| 2015 | Efficient and Safe Lentiviral Vector-Mediated Hematopoietic Stem Cell Gene Thera... | |
| 2015 | Molecular characterization of ten F8 splicing mutations in RNA isolated from pat... | |
| 2014 | Thymidine phosphorylase is both a therapeutic and a suicide gene in a murine mod... | |
| 2014 | Hematopoietic chimerisms: friends or foes? | |
| 2014 | Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotid... | |
| 2014 | Myeloid-derived suppressor cells are generated during retroviral transduction of... | |
| 2013 | Next-generation scholarly communication: A researcher's perspective | |
| 2013 | Bone marrow transplantation in dysferlin-deficient mice results in a mild functi... | |
| 2012 | Notch signals contribute to preserve the multipotentiality of human CD34(+)CD38(... | |
| 2011 | Myeloid-derived suppressor cells (MDSC): Another player in the orchestra | |
| 2011 | Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell c... | |
| 2010 | Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradi... | |
| 2009 | Transgene expression levels determine the immunogenicity of transduced hematopoi... | |
| 2009 | Bone Marrow Transplantation Induces Normoglycemia in a Type 2 Diabetes Mellitus ... | |
| 2009 | Identification of multipotent mesenchymal stromal cells in the reactive stroma o... | |
| 2009 | Tolerance Induction in Experimental Autoimmune Encephalomyelitis Using Non-myelo... | |
| 2008 | Estrogen receptor beta displays cell cycle-dependent expression and regulates th... | |
| 2006 | Flow cytometry of the Side Population: tips & tricks | |
| 2006 | The Hoechst low-fluorescent profile of the side population: clonogenicity versus... | |
| 2005 | A rare fraction of human hematopoietic stem cells with large telomeres | |
| 2005 | Therapeutic applications of stem-cells | |
| 2005 | [Stem cells for the treatment of hearing loss] | |
| 2004 | Flow cytometry-based approach to ABCG2 function suggests that the transporter di... | |
| 2004 | Retroviral vectors: new applications for an old tool. | |
| 2002 | Myeloablation enhances engraftment of transduced murine hematopoietic cells, but... | |
| 2001 | Stem cell gene therapy: myths an realities | |
| 1997 | High-titer retroviral vectors containing the enhanced green fluorescent protein ... | |
| 1995 | Allogeneic marrow grafts from donors with congenital chromosomal abnormalities i... | |
| 1994 | ANTIBODIES AGAINST PLATELET-ACTIVATING-FACTOR IN PATIENTS WITH ANTIPHOSPHOLIPID ... | |
| 1992 | VALVULAR HEART-DISEASE IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME | |
| 1990 | Polymyositis and cyclosporin A. | |
| 1990 | ANTICARDIOLIPIN ANTIBODIES AND BINDING OF ANIONIC PHOSPHOLIPIDS AND SERUM-PROTEI... | |
| 1989 | FETAL LOSS TREATMENT IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES | |
| 1989 | The "primary" antiphospholipid syndrome: major clinical and serological features... | |
| 1989 | [Antiphospholipid antibodies and rickettsia infections]. | |
| 1988 | SNEDDONS SYNDROME AND ANTICARDIOLIPIN ANTIBODIES | |
| 1988 | Anticardiolipin antibodies and migraine-related strokes. | |
| 1988 | LUPUS ANTICOAGULANT AND PORTAL-HYPERTENSION | |
| 1986 | SERUM THROMBOCYTOPENIA AND HIGH-DOSE IMMUNOGLOBULIN TREATMENT |
Col·laboracions institucionals darrers 5 anys
